| Syndrome | Antibody/Mechanism | Frequency | Clinical Features |
|---|---|---|---|
| LEMS | Anti-VGCC (P/Q-type) | 3–5% of SCLC | Proximal weakness, autonomic dysfunction, areflexia |
| SIADH | Ectopic ADH secretion | 10–15% of SCLC | Hyponatremia, confusion, seizures |
| PCD | Anti-Yo, anti-Hu | 1–3% of SCLC | Cerebellar ataxia, dysarthria, nystagmus |
| Encephalomyelitis | Anti-Hu, anti-CRMP5 | 1–2% of SCLC | Cognitive decline, seizures, sensory neuropathy |
ACS may occur coincidentally in cancer patients due to shared risk factors (smoking, age) or chemotherapy cardiotoxicity, but it is NOT a paraneoplastic phenomenon.
LASH — LEMS, Antibodies (anti-Hu, anti-Yo), SIADH, Hypercoagulability (thrombosis, not ACS)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →